 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal Achievement in Patients With Recent Ischemic Stroke: A Randomized Controlled Trial |
| Keun-Sik Hong, Oh Young Bang, Jong-Ho Park, Jin-Man Jung, Sang-Hun Lee, Tae-Jin Song, Hyo Suk Nam, Hee-Kwon Park, Keun-Hwa Jung, Sung Hyuk Heo, Jaseong Koo, Kyung-Ho Yu, Kwang-Yeol Park, Chi Kyung Kim, Hong-Kyun Park, Jiyoon Lee, Juneyoung Lee, Woo-Keun Seo |
|
J Stroke. 2023;25(2):242-250. Published online April 11, 2023 DOI: https://doi.org/10.5853/jos.2022.02957 |
|
Moderate-Intensity Rosuvastatin Plus Ezetimibe Versus High-Intensity Rosuvastatin for Target Low-Density Lipoprotein Cholesterol Goal Achievement in Patients With Recent Ischemic Stroke: A Randomized Controlled Trial Journal of Stroke. 2023;25(2):242-250  Time needed to achieve the steady state low density lipoprotein cholesterol levels with high-intensity rosuvastatin plus ezetimibe therapy in patients with acute coronary syndrome Indian Heart Journal. 2022;74:S35 Effect of High-Intensity Rosuvastatin vs. Combination of Low-Intensity Rosuvastatin and Ezetimibe on HbA1c Levels in Patients without Diabetes: A Randomized IDEAL Trial Journal of Clinical Medicine. 2023;12(18):6099 Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified by National Cholesterol Education Program Risk Category Metabolic Syndrome and Related Disorders. 2009;7(6):601-610 Predictive Value of the Low-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio for the Prevention of Stroke Recurrence in Japanese Patients Treated with Rosuvastatin Clinical Drug Investigation. 2012;32(8):513-521 HIGH-INTENSITY VERSUS NON-HIGH-INTENSITY STATINS IN PATIENTS ACHIEVING LOW-DENSITY LIPOPROTEIN CHOLESTEROL GOAL AFTER PERCUTANEOUS CORONARY INTERVENTION Journal of the American College of Cardiology. 2019;73(9):1750 P252 A RANDOMIZED COMPARISON OF ROSUVASTATIN PLUS EZETIMIBE VERSUS SIMVASTATIN PLUS EZETIMIBE: RESULTS OF THE GRAVITY STUDY Atherosclerosis Supplements. 2010;11(2):69 Effects of Fixed-dose Combination of Low-intensity Rosuvastatin and Ezetimibe Versus Moderate-intensity Rosuvastatin Monotherapy on Lipid Profiles in Patients With Hypercholesterolemia: A Randomized, Double-blind, Multicenter, Phase III Study Clinical Therapeutics. 2021;43(9):1573-1589 Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: Results of the GRAVITY randomized study Atherosclerosis. 2014;232(1):86-93 Treatment Patterns And Lack of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Attainment Among High-Risk Patients Using High or Moderate Intensity Statin Therapy In Germany Value in Health. 2017;20(9):A603 |
